We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Characteristics of Acute Pulmonary Embolism in Chinese Population

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02214043
Recruitment Status : Completed
First Posted : August 12, 2014
Last Update Posted : January 30, 2018
Sponsor:
Information provided by (Responsible Party):
Chinese Pulmonary Vascular Disease Research Group

Brief Summary:
There are no special clinical characteristics of acute pulmonary embolism in Chinese population.

Condition or disease
Pulmonary Embolism

Study Type : Observational [Patient Registry]
Actual Enrollment : 600 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 5 Years
Official Title: Clinical Characteristics of Acute Pulmonary Embolism in Chinese Population
Study Start Date : January 2012
Primary Completion Date : December 2017
Study Completion Date : December 2017

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Group/Cohort
Group 2
group 1



Primary Outcome Measures :
  1. The primary end point of the present study was symptomatic, objectively confirmed recurrent fatal or nonfatal VTE. [ Time Frame: 60 months ]

Secondary Outcome Measures :
  1. The second end point was death (all cause death and PE-related death). [ Time Frame: 60 months ]
    If the participant died, the relatives need provided the written medical record on the death.


Biospecimen Retention:   Samples Without DNA
BNP,D-dimer


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   15 Years to 85 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Acute pulmonary embolism in Chinese population
Criteria

Inclusion Criteria:

  • the symptomatic acute PE confirmed by objective examination

Exclusion Criteria:

  • congestive heart failure
  • chronic obstructive pulmonary disease;
  • a prior documented episode of PE or DVT
  • renal dysfunction;
  • a life expectancy of less than 6 months

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02214043


Locations
China
Center of pumonary vascular diseases
Beijing, China, 100037
Sponsors and Collaborators
Chinese Pulmonary Vascular Disease Research Group
Investigators
Study Chair: Zhihong Liu, Doctor Chinese pulmonary vascular disease organization group

Responsible Party: Chinese Pulmonary Vascular Disease Research Group
ClinicalTrials.gov Identifier: NCT02214043     History of Changes
Other Study ID Numbers: APEINCP
First Posted: August 12, 2014    Key Record Dates
Last Update Posted: January 30, 2018
Last Verified: July 2016

Additional relevant MeSH terms:
Embolism
Pulmonary Embolism
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases
Lung Diseases
Respiratory Tract Diseases